A nationwide community-based lifestyle program could delay or prevent type 2 diabetes cases and save $5.7 billion in 25 years

Health Affairs

Volumn 31, Issue 1, 2012, Pages 50-60

  Zhuo, Xiaohui ^a   Zhang, Ping ^a   Gregg, Edward W ^a   Barker, Lawrence ^b   Hoerger, Thomas J ^b   Pearson Clarke, Tony ^c   Albright, Ann ^c  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b RTI UNC Center of Excellence in Health Promotion Economics   (United States)

^c NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ECONOMIC ASPECT; HEALTH CARE COST; HEALTH CARE ORGANIZATION; HEALTH INSURANCE; HUMAN; INTERVENTION STUDY; LIFESTYLE; MEDICAL EDUCATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVENTION; PUBLIC HEALTH; SIMULATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; COMMUNITY NETWORKS; COST OF ILLNESS; COST SAVINGS; DIABETES MELLITUS, TYPE 2; FEMALE; FORECASTING; HUMANS; MALE; MIDDLE AGED; MODELS, THEORETICAL; RISK REDUCTION BEHAVIOR; UNITED STATES; YOUNG ADULT;

EID: 84855679024     PISSN: 02782715     EISSN: 15445208     Source Type: Journal    
DOI: 10.1377/hlthaff.2011.1115     Document Type: Article

References (41)

1. Centers for Disease Control and Prevention. National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011 [Internet]. Atlanta (GA): CDC; 2011 [cited 2011 Dec 7]. Available from: http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2011.pdf
2. American Diabetes Association. Economic costs of diabetes in the U.S. in 2007. Diabetes Care. 2008; 31(3):596-615.
3. Huang ES, Basu A, O'Grady M, Capretta JC. Projecting the future diabetes population size and related costs for the U.S. Diabetes Care. 2009;32(12):2225-9.
4. Centers for Disease Control and Prevention. National Diabetes Prevention Program [home page on the Internet]. Atlanta (GA): CDC; [last updated 2011 Nov 14; cited 2011 Dec 6]. Available from: http://www.cdc.gov/diabetes/projects/prevention_program.htm
5. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6): 393-403.
6. Ackermann RT, Finch EA, Brizendine E, Zhou H, Marrero DG. Translating the Diabetes Prevention Program into the community. The DEPLOY Pilot Study. Am J Prev Med. 2008;35(4):357-63.
7. Ackermann RT, Marrero DG. Adapting the Diabetes Prevention Program lifestyle intervention for delivery in the community: the YMCA model. Diabetes Educ. 2007;33(1):69, 74-5, 77-8.
8. To access the Appendix, click on the Appendix link in the box to the right of the article online
9. Centers for Disease Control and Prevention. National Ambulatory Medical Care Survey: 2008 summary tables [Internet]. Atlanta (GA): CDC; [accessed 2011 Dec 16]. Available from: http://www.cdc.gov/nchs/ data/ahcd/namcs_summary/ namcssum2008.pdf
10. Pleis JR, Ward BW, Lucas JW. Summary health statistics for U.S. adults: National Health Interview Survey, 2009. Vital Health Stat 10. 2010 Dec; (249):1-207.
11. Herman WH, Smith PJ, Thompson TJ, Engelgau MM, Aubert RE. A new and simple questionnaire to identify people at increased risk for undiagnosed diabetes. Diabetes Care. 1995;18(3): 382-7.
12. Bullard KM, Williamson DF, Imperatore G, Gregg EW. Identification of US adults with pre-diabetes or undiagnosed diabetes using a simple risk score. Diabetes. 2011; 60(Suppl 1):A357.
13. Centers for Disease Control and Prevention. National Health and Nutrition Examination Survey [home page on the Internet]. Atlanta (GA): CDC; [last updated 2011 Nov 30; cited 2011 Dec 8]. Available from: http://www.cdc.gov/ nchs/nhanes.htm
14. Scheltens T, Bots ML, Numans ME, Grobbee DE, Hoes AW. Awareness, treatment and control of hypertension: the "rule of halves" in an era of risk-based treatment of hypertension. J Hum Hypertens. 2007;21(2): 99-106.
15. Crandall JP, Knowler WC, Kahn SE, Marrero D, Florez JC, Bray GA, et al. The prevention of type 2 diabetes. Nat Clin Pract Endocrinol Metab. 2008;4(7):382-93.
16. De Geest S, Sabaté E. Adherence to long-term therapies: evidence for action. Eur J Cardiovasc Nurs. 2003; 2(4):323.
17. Knowler WC, Fowler SE, Hamman RF, Christophi CA, Hoffman HJ, Brenneman AT, et al. 10-year followup of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet. 2009; 374(9702):1677-86.
18. Herman WH, Diabetes Prevention Program Outcomes Study Group. The 10-year cost-effectiveness of lifestyle intervention or metformin for the primary prevention of type 2 diabetes mellitus: an intent-to-treat analysis of the Diabetes Prevention Program/Diabetes Prevention Program Outcomes Study. Abstract of paper presented at: 71st scientific session of the American Diabetes Association; 2011 Jun 24-28; San Diego, CA.
19. Absetz P, Oldenburg B, Hankonen N, Valve R, Heinonen H, Nissinen A, et al. Type 2 diabetes prevention in the real world: three-year results of the GOAL lifestyle implementation trial. Diabetes Care. 2009;32(8): 1418-20.
20. Parikh P, Simon EP, Fei K, Looker H, Goytia C, Horowitz CR. Results of a pilot diabetes prevention intervention in East Harlem, New York City: Project HEED. Am J Public Health. 2010;100(Suppl 1):S232-9.
21. Katula JA, Vitolins MZ, Rosenberger EL, Blackwell CS, Morgan TM, Lawlor MS, et al. Oneyear results of a community-based translation of the Diabetes Prevention Program: Healthy-Living Partnerships to Prevent Diabetes (HELP PD) Project. Diabetes Care. 2011; 34(7):1451-7.
22. Hamman RF, Wing RR, Edelstein SL, Lachin JM, Bray GA, Delahanty L, et al. Effect of weight loss with lifestyle intervention on risk of diabetes. Diabetes Care. 2006;29(9):2102-7.
23. Norris SL, Zhang X, Avenell A, Gregg E, Bowman B, Schmid CH, et al. Long-term effectiveness of weight-loss interventions in adults with pre-diabetes: a review. Am J Prev Med. 2005;28(1):126-39.
24. Herman WH, Hoerger TJ, Brandle M, Hicks K, Sorensen S, Zhang P, et al. The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance. Ann Intern Med. 2005;142(5): 323-32.
25. Hoerger TJ, Segel JE, Zhang P, Sorensen SW. Validation of the CDCRTI diabetes cost-effectiveness model [Internet]. Research Triangle Park (NC): RTI International; 2009 Sep [cited 2011 Dec 8]. Available from: http://www.rti.org/pubs/ mr-0013-0909-hoerger.pdf
26. CDC Cost-Effectiveness Study Group. Cost-effectiveness of intensive glycemic control, intensified hypertension control, and serum cholesterol level reduction for type 2 diabetes. JAMA. 2002;287(19):2542-51.
27. Census Bureau. 2009 national population projections (supplemental) [Internet].Washington (DC): Census Bureau; [cited 2011 Dec 8]. Available from: http://www.census.gov/ population/www/projections/ 2009projections.html
28. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. Am J Epidemiol, 1989;129(4): 687-702.
29. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998;352 (9131):837-53.
30. Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, et al. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2009; 32(1):193-203.
31. Brandle M, Zhou H, Smith BR, Marriott D, Burke R, Tabaei BP, et al. The direct medical cost of type 2 diabetes. Diabetes Care. 2003; 26(8):2300-4.
32. Agency for Healthcare Research and Quality. Medical Expenditure Examination Survey [home page on the Internet]. Rockville (MD): AHRQ; [cited 2011 Dec 8]. Available from: http://www.meps.ahrq.gov/ mepsweb/index.jsp
33. Centers for Medicare and Medicaid Services. Prevention data website- user's guide [Internet]. Washington (DC): CMS; [cited 2011 Dec 16]. Available from: http://www.cms.gov/prevntiongeninfo/downloads/ps_dug.pdf
34. Aldana SG, Merrill RM, Price K, Hardy A, Hager R. Financial impact of a comprehensive multisite workplace health promotion program. Prev Med. 2005;40(2):131-7.
35. Aldana SG. Financial impact of health promotion programs: a comprehensive review of the literature. Am J Health Promot. 2001;15(5): 296-320.
36. Zhang P, Hoerger T, Ackermann R. Are the costs of a highly effective lifestyle intervention to prevent diabetes in high-risk individuals acceptable to all stakeholders? Abstract of paper presented at: 68th scientific session of the American Diabetes Association; 2008 Jun 6-10; San Francisco, CA.
37. Johnson FR, Manjunath R, Mansfield CA, Clayton LJ, Hoerger TJ, Zhang P. High-risk individuals' willingness to pay for diabetes risk-reduction programs. Diabetes Care. 2006;29(6):1351-6.
38. Li R, Zhang P, Barker LE, Chowdhury FM, Zhang X. Costeffectiveness of interventions to prevent and control diabetes mellitus: a systematic review. Diabetes Care. 2010;33(8):1872-94.
39. Colagiuri S, Walker AE. Using an economic model of diabetes to evaluate prevention and care strategies in Australia. Health Aff (Millwood). 2008;27(1):256-68.
40. Castro-Ríos A, Doubova SV, Martínez-Valverde S, Coria-Soto I, Perez-Cuevas R. Potential savings in Mexico from screening and prevention for early diabetes and hypertension. Health Aff (Millwood). 2010;29(12):2171-9.
41. Thorpe KE, Yang Z. Enrolling people with prediabetes ages 60-64 in a proven weight loss program could save Medicare $7 billion or more. Health Aff (Millwood). 2011; 30(9):1673-9.